AIDS 2014: Activists hold die-in to protest high price of Gilead’s hepatitis C drug

By on .

AIDS2014postScience Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the week, with updates on research, policy and insights from the 20th International AIDS Conference.

Photo by Alissa Sadler

Photo by Alissa Sadler

MELBOURNE, AUSTRALIA –  Activists surprised Gilead corporate executives today with a “die-in” to protest the pricing of Gilead’s hepatitis C drug, Solvaldi (sofosbuvir). As Gregg Alton, Gilead’s Executive Vice-President of Corporate and Medical Affairs spoke, activists rushed the room bringing Alton a cow’s liver on a silver platter chanting “Pills Cost Pennies, Greed Costs Lives” and a variety of other slogans. Alton and other Gilead executives have defended the price of the drugs claiming that the treatment is cheaper than a liver transplant.

Hepatitis C is prevalent among people who inject drugs, and widespread in low and middle-income countries.  Worldwide, an estimated 150 million people have hepatitis C and it kills an estimated 500,000 people every year.

2 thoughts on “AIDS 2014: Activists hold die-in to protest high price of Gilead’s hepatitis C drug

  1. Pingback: AIDS 2014: Activists Hold Die-In to Protest High Price of Gilead’s Hepatitis C Drug | Don't trade our lives away

  2. Pingback: Gilead, sofosbuvir, and hepatitis C . . . We’re reading about the high cost of living | Science Speaks: HIV & TB News

Leave a Comment

Your email address will not be published. Required fields are marked *